Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
1.
Eur Arch Psychiatry Clin Neurosci ; 272(4): 583-590, 2022 Jun.
Article in English | MEDLINE | ID: mdl-34420073

ABSTRACT

Despite national and international recommendations and while there is no evidence for increased efficacy of higher doses, several studies suggested that the prescribed doses in routine practice are higher than the maximal recommended doses in 20-40% of schizophrenia patients worldwide. METHODS: the aims of the present study were: (1) to describe the patterns of antipsychotic daily dose prescriptions in routine clinical practice in a large and representative cohort of French schizophrenia patients and, (2) to study the characteristics of patients receiving higher doses. RESULTS: in all cases, regardless of the antipsychotic treatment used, the average dose was greater than 1.0 defined daily dose (DDDeq), which is the average recommended dose. For SGA, the mean DDDeq ranged from 1.2 for aripiprazole to 1.6 for olanzapine and clozapine, respectively. For a given patient, the mean ± S.D. total daily cumulative dose (TCD) of antipsychotic was 1.9 ± 2.4 DDDeq. A "high dose" was defined as a TCD ≥ 1.5 DDDeq, 789 (45.2%) patients received a "high dose". Patients in the "high dose" group were more frequently suffering from a more severe paranoid schizophrenia, had more often a comorbid antisocial personality disorder and/or a substance use disorder. CONCLUSIONS: the present study suggests that in France, antipsychotic drugs doses prescribed by psychiatrists are higher, compared to other countries. All recommendations agree on the fact that the preferential dose should be the "minimum-effective" dose. Optimizing prescribing practices would be important to optimize the benefit/risk ratio and to minimize the risks side effects.


Subject(s)
Antipsychotic Agents , Clozapine , Schizophrenia , Antipsychotic Agents/therapeutic use , Clozapine/therapeutic use , Cohort Studies , Humans , Olanzapine/therapeutic use , Schizophrenia/chemically induced , Schizophrenia/drug therapy
2.
Rev Med Liege ; 76(4): 268-272, 2021 Apr.
Article in French | MEDLINE | ID: mdl-33830691

ABSTRACT

Paedophilia is a paraphilia characterised by behaviour, drives or sexual fantasies that are intense and recurring and that generally involve children. This sexual deviation is often linked to personal distress, to a significant alteration of personal, family, professional and social life, in a general sense. In our modern Western societies, paedophilia and the perversions associated with it are punishable by law. Paedophilia is a concept that is very ancient, complex and particularly diverse in its many clinical presentations. Its societal impact is very important and contrasts with the real knowledge of this issue among non-specialists, or even among specialists. In this second part of the article, the authors will develop the aetiologies of paedophilia, the therapeutic options and the forensic aspects.


La pédophilie est une paraphilie caractérisée par des comportements, des pulsions ou des fantasmes sexuels intenses et récurrents qui impliquent, de manière générale, les enfants. Cette déviance sexuelle s'accompagne souvent d'une souffrance personnelle, d'une altération significative du fonctionnement personnel, familial, professionnel et, au sens large, social. Dans nos sociétés occidentales modernes, la pédophilie et les perversions s'y rapportant sont condamnées par la loi. La pédophilie est un concept très ancien, complexe et surtout hétérogène. Son impact sociétal est très important et contraste avec le degré de connaissance réel de cette déviance parmi les non spécialistes et même parmi les spécialistes. Dans la seconde partie de cet article, les auteurs vont développer les hypothèses étiologiques, les principales options thérapeutiques et quelques aspects médico-légaux.


Subject(s)
Pedophilia , Child , Humans , Pedophilia/therapy
3.
Rev Med Liege ; 76(3): 195-201, 2021 Mar.
Article in French | MEDLINE | ID: mdl-33682389

ABSTRACT

Paedophilia is a paraphilia characterised by behaviour, drives or sexual fantasies that are intense and recurring and that involve children, in a general sense. This sexual deviation is often linked to personal distress, to a significant alteration of personal, family, professional and social life, in a general sense. In our modern Western societies, paedophilia and the perversions associated with it are punishable by law. Paedophilia is a concept that is very ancient, complex and particularly diverse in its many clinical presentations. Its societal impact is very important and contrasts with the real knowledge of this issue among non-specialists, or even among specialists. Based on expert clinical experience gathered at the courts and on an exhaustive review of current literature on the subject, the authors propose an update of the concept of paedophilia. In the first part of this work, the authors will discuss several aspects such as the historical background and the clinical aspects and nosography of paedophilia. This literature review will be accompanied by short clinical vignettes, based on the authors' clinical experience.


La pédophilie est une paraphilie caractérisée par des comportements, des pulsions ou des fantasmes sexuels intenses et récurrents qui impliquent, de manière générale, les enfants. Cette déviance sexuelle s'accompagne souvent d'une souffrance personnelle, d'une altération significative du fonctionnement personnel, familial, professionnel et, de manière générale, social. Dans nos sociétés occidentales modernes, la pédophilie et les perversions s'y rapportant sont condamnées par la loi. La pédophilie est un concept très ancien, complexe et surtout hétérogène. Son impact sociétal est très important et contraste avec le degré de connaissance réel de cette déviance parmi les non-spécialistes et même parmi les spécialistes. En se basant sur une expérience clinique d'expert auprès des tribunaux et sur une revue exhaustive de la littérature actuelle, les auteurs proposent une actualisation du concept de pédophilie. Cette revue de littérature sera accompagnée de courtes vignettes cliniques issues de l'expérience clinique des auteurs.


Subject(s)
Pedophilia , Child , Humans
4.
Dialogues Clin Neurosci ; 23(1): 39-43, 2021.
Article in English | MEDLINE | ID: mdl-35860173

ABSTRACT

Introduction: Chemsex is defined by the use of psychoactive substances to facilitate or improve sexual relations. Our objectives were to assess the prevalence of the practice of 'chemsex' in a population of French university students and to identify socio-demographic and clinical factors associated with this practice. Material and methods: We have used an anonymous online questionnaire comprising 15 questions on socio-demographic characteristics, chemsex use, sexual satisfaction, the type of substances used in this sexual context and their route of administration. Results: A total of 680 people were included in our study. Among them, 22.5% reported chemsex behaviour in the past year. Using a multivariate analysis, factors associated with chemsex were dating application use (p = 0.049) and pornography use [viewing more than once per month (p = 0.002)]. Having a sexual partner involved in chemsex (p < 0.0001), celibacy (p = 0.007), sexual orientations other than heterosexual (p = 0.0013) and especially bisexuality (p = 0.0002) were also significantly associated with chemsex. Conclusion: This is the first study reporting a high prevalence of chemsex in a university student population. Further larger studies should be conducted to confirm these results showing a high prevalence of this at-risk behaviour.


Subject(s)
Illicit Drugs , Psychotropic Drugs , Sexual Behavior , Substance-Related Disorders , France/epidemiology , Humans , Prevalence , Psychotropic Drugs/administration & dosage , Sexual Behavior/drug effects , Sexuality/drug effects , Students/statistics & numerical data , Substance-Related Disorders/epidemiology , Universities/statistics & numerical data
5.
Encephale ; 46(3S): S43-S52, 2020 Jun.
Article in French | MEDLINE | ID: mdl-32370983

ABSTRACT

The psychological effects of isolation have already been described in the literature (polar expeditions, submarines, prison). Nevertheless, the scale of confinement implemented during the COVID-19 pandemic is unprecedented. In addition to reviewing the published studies, we need to anticipate the psychological problems that could arise during or at a distance from confinement. We have gone beyond the COVID-19 literature in order to examine the implications of the known consequences of confinement, like boredom, social isolation, stress, or sleep deprivation. Anxiety, post-traumatic stress disorder, depression, suicidal or addictive behaviours, domestic violence are described effects of confinement, but the mechanisms of emergence of these disorders and their interrelationships remain to be studied. For example, what are the mechanisms of emergence of post-traumatic stress disorders in the context of confinement? We also remind the reader of points of vigilance to be kept in mind with regard to eating disorders and hallucinations. Hallucinations are curiously ignored in the literature on confinement, whereas a vast literature links social isolation and hallucinations. Due to the broad psychopathological consequences, we have to look for these various symptoms to manage them. We quickly summarize the diagnostic and therapeutic approaches already in place, such as telemedicine, which is undergoing rapid development during the COVID-19 crisis.


Subject(s)
Betacoronavirus , Coronavirus Infections , Pandemics , Patient Isolation/psychology , Pneumonia, Viral , Social Isolation/psychology , Adult , Anxiety Disorders/etiology , Anxiety Disorders/psychology , Behavior, Addictive/etiology , Behavior, Addictive/psychology , Boredom , COVID-19 , Child , Child Abuse , Coronavirus Infections/psychology , Delivery of Health Care , Depression/etiology , Depression/psychology , Domestic Violence/psychology , Feeding and Eating Disorders/etiology , Feeding and Eating Disorders/psychology , France , Hallucinations/etiology , Hallucinations/psychology , Health Services Accessibility , Humans , Mental Health Services/organization & administration , Pneumonia, Viral/psychology , SARS-CoV-2 , Sleep Wake Disorders/etiology , Sleep Wake Disorders/psychology , Stress Disorders, Post-Traumatic/etiology , Stress Disorders, Post-Traumatic/psychology , Suicide/psychology , Telemedicine
6.
Article in English | MEDLINE | ID: mdl-29097256

ABSTRACT

Parkinson's disease (PD) is a progressive degenerative disorder that leads to disabling motor symptoms and a wide variety of neuropsychiatric symptoms. Apathy is the most common psychiatric disorder in the early stages of untreated PD and can be defined as a hypodopaminergic syndrome, which also includes anxiety and depression. Apathy is also considered the core feature of the parkinsonian triad (apathy, anxiety and depression) of behavioural non-motor signs, including a motivational deficit. Moreover, apathy is recognised as a distinct chronic neuropsychiatric behavioural disorder based on specific diagnostic criteria. Given the prevalence of apathy in approximately 40% of the general Parkinson's disease population, this appears to be a contributing factor to dementia in PD; also, apathy symptoms are factors that potentially contribute to morbidity, leading to a major impairment of health-related quality of life, thus stressing the importance of understanding the pathophysiology of this disease. Several studies have clearly established a prominent role for DA-mediated signals in PD apathy. However, synergistic interaction between dopaminergic impairment resulting from the neurodegenerative process and deep brain stimulation of the subthalamic nucleus may cause or exacerbate apathy. Furthermore, serotoninergic mechanism signalling is also likely to be of importance in this pathophysiology.


Subject(s)
Brain/physiopathology , Motivation/physiology , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Animals , Humans , Parkinson Disease/diagnosis , Parkinson Disease/epidemiology
7.
Genet Mol Res ; 15(4)2016 Oct 17.
Article in English | MEDLINE | ID: mdl-27813593

ABSTRACT

Klinefelter syndrome (KS) is the most common sex chromosomal disorder with an estimated prevalence of 1 in 500-1000. Increased incidences of anxiety, depression, substance abuse, psychotic and behavioral disorders, and sexual disorders have been reported in patients with KS. The aim of this case study was to report a case of a man with untreated KS who was also diagnosed with type II bipolar disorder. This case report raises awareness regarding psychiatric diagnoses that may be associated with such a highly prevalent condition. A 46-year-old man who had previously been diagnosed with an untreated KS was examined in our Psychiatric Department with an acute hypomanic episode. Clinical improvement was observed within 4 days and psychiatric symptoms were resolved in 7 days without use of medication. A psychiatric history of a depressive episode and at least two hypomanic episodes, as well as a family history of two relatives diagnosed with bipolar disorder, strongly suggest that our patient has type II bipolar disorder. Bipolar disorder may be a comorbid disorder in patients with KS. Routine screening for mood disorders and appropriate referral and evaluation should be performed. Future genetic research is warranted to explore why some chromosomal abnormalities (e.g., duplications), especially those located on the X chromosome, such as Klinefelter syndrome, may be associated with a bipolar or psychotic disorder in some individuals but not in others.


Subject(s)
Bipolar Disorder/complications , Klinefelter Syndrome/complications , Bipolar Disorder/drug therapy , Humans , Klinefelter Syndrome/drug therapy , Male , Middle Aged
8.
Article in English | MEDLINE | ID: mdl-27495357

ABSTRACT

The relatively common view indicates a possible dissociation between the anxiolytic and sedative/hypnotic properties of benzodiazepines (BZs). Indeed, GABAA receptor (GABAAR) subtypes have specific cerebral distribution in distinct neural circuits. Thus, GABAAR subtype-selective drugs may be expected to perform distinct functions. However, standard behavioral test assays provide limited direction towards highlighting new action mechanisms of ligands targeting GABAARs. Automated behavioral tests, lack sensitivity as some behavioral characteristics or subtle behavioral changes of drug effects or that are not considered in the overall analysis (Ohl et al., 2001) and observation-based analyses are not always performed. In addition, despite the use of genetically engineered mice, any possible dissociation between the anxiolytic and sedative properties of BZs remains controversial. Moreover, the involvement the different subtypes of GABAAR subtypes in the anxious behavior and the mechanism of action of anxiolytic agents remains unclear since there has been little success in the pharmacological investigations so far. This raises the question of the involvement of the different subunits in anxiolytic-like and/or sedative effects; and the actual implication of these subunits, particularly, α-subunits in the modulation of sedation and/or anxiety-related disorders. This present review was prompted by several conflicting studies on the degree of involvement of these subunits in anxiolytic-like and/or sedative effects. To this end, we explored the GABAergic system, particularly, the role of different subunits containing synaptic GABAARs. We report herein the targeting gene encoding the different subunits and their contribution in anxiolytic-like and/or sedative actions, as well as, the mechanism underlying tolerance to BZs.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , GABA Modulators/therapeutic use , Hypnotics and Sedatives/therapeutic use , Receptors, GABA-A/metabolism , Animals , Humans
9.
Article in English | MEDLINE | ID: mdl-26739950

ABSTRACT

5-HT2Rs have a different genomic organization from other 5-HT2Rs. 5HT2CR undergoes post-transcriptional pre-mRNA editing generating diversity among RNA transcripts. Selective post-transcriptional editing could be involved in the pathophysiology of psychiatric disorders through impairment in G-protein interactions. Moreover, it may influence the therapeutic response to agents such as atypical antipsychotic drugs. Additionally, 5-HT2CR exhibits alternative splicing. Central serotonergic and dopaminergic systems interact to modulate normal and abnormal behaviors. Thus, 5HT2CR plays a crucial role in psychiatric disorders. 5HT2CR could be a relevant pharmacological target in the treatment of neuropsychiatric disorders. The development of drugs that specifically target 5-HT2C receptors will allow for better understanding of their involvement in the pathophysiology of psychiatric disorders including schizophrenia, anxiety, and depression. Among therapeutic means currently available, most drugs used to treat highly morbid psychiatric diseases interact at least partly with 5-HT2CRs. Pharmacologically, 5HT2CRs, have the ability to generate differentially distinct response signal transduction pathways depending on the type of 5HT2CR agonist. Although this receptor property has been clearly demonstrated, in vitro, the eventual beneficial impact of this property opens new perspectives in the development of agonists that could activate signal transduction pathways leading to better therapeutic efficiency with fewer adverse effects.


Subject(s)
Mental Disorders/metabolism , Receptor, Serotonin, 5-HT2C/metabolism , Humans , Mental Disorders/genetics , Receptor, Serotonin, 5-HT2C/genetics
10.
Encephale ; 41 Suppl 1: S13-20, 2015 Jun.
Article in French | MEDLINE | ID: mdl-25439854

ABSTRACT

BACKGROUND: Substance use has increased worldwide. Based on these data, we may think that substance use has also increased during pregnancy, but epidemiological data are scarce in this population. The potential consequences of tobacco, cocaine or cannabis use during pregnancy are a major public health concern. The combined use of different substances during pregnancy may have serious consequences on the pregnancy and on child development. METHODS: In this paper, we will describe the potential consequences for the newborn, child and adolescent after being exposed to tobacco, cannabis and cocaine in utero. For this purpose, we will review all retrospective and prospective studies (in English and French) referenced in PubMed reporting on the somatic or psychiatric consequences of alcohol, tobacco and drug consumption by pregnant women on newborn and children. Consumption during pregnancy was assessed in these studies using simple questionnaires, biomarkers analysis or both. RESULTS: Generally speaking, these pregnancies are at high risk for both the mother and the foetus: for example, an increased risk of miscarriage or of reduced length of gestation, an increased risk of uterine apoplexy and placenta praevia, more premature births and/or hypotrophy were reported. The occurrence of a newborn's withdrawal syndrome may be misdiagnosed. Many consequences on child development may be observed such as growth disorders, learning or motor disorders, language disorders, cognitive disorders (attention, memory, executive functions), attention deficit disorders with impulsivity or with hyperactivity (ADHD), and memory disorders. The prevalence of depressive or anxiety disorders may also be increased in these children. The risk of addictive disorders or schizophrenia in children exposed in utero to illicit drugs or tobacco is still unknown. The combined use of different substances increases, consequently it is difficult to disentangle the consequences on child development of each of the drugs used during pregnancy owing to potential interactions between these drugs. The consequences on child development will also depend on the dose and on the time of drug use during pregnancy. DISCUSSION: The National Institute of Drug Abuse reported that 75% of the infants exposed in utero to one or more substances will present medical problems during childhood, as compared to only 27% of the non-exposed infants. However, the medical consequences are still a matter of controversies. Methodological biases, such as the use of different rating scales among studies, and the heterogeneity of the populations included are main limitations. Further studies are needed using larger cohorts and longer follow-up periods.


Subject(s)
Alcoholism/complications , Alcoholism/epidemiology , Developmental Disabilities/chemically induced , Developmental Disabilities/epidemiology , Fetal Alcohol Spectrum Disorders/epidemiology , Marijuana Abuse/complications , Marijuana Abuse/epidemiology , Neonatal Abstinence Syndrome/epidemiology , Pregnancy Complications/epidemiology , Pregnancy Complications/etiology , Prenatal Exposure Delayed Effects , Smoking/adverse effects , Smoking/epidemiology , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Female , Fetal Alcohol Spectrum Disorders/diagnosis , France , Humans , Infant , Infant, Newborn , Neonatal Abstinence Syndrome/diagnosis , Pregnancy
11.
Eur J Phys Rehabil Med ; 51(4): 389-97, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25375186

ABSTRACT

BACKGROUND: Spasticity is a frequent complication after severe brain injury, which may impede the rehabilitation process and diminish the patients' quality of life. AIM: We here investigate the presence of spasticity in a population of non-communicative patients with disorders of consciousness. We also evaluate the correlation between spasticity and potential factors of co-morbidity, frequency of physical therapy, time since insult, presence of pain, presence of tendon retraction, etiology and diagnosis. DESIGN: Cross-sectional study. SETTING: University Hospital of Liège, Belgium. POPULATION: Sixty-five patients with chronic (>3 months post insult) disorders of consciousness were included (22 women; mean age: 44±14 y; 40 with traumatic etiology; 40 in a minimally conscious state; time since insult: 39±37 months). METHODS: Spasticity was measured with the Modified Ashworth Scale (MAS) and pain was assessed using the Nociception Coma Scale-Revised (NCS-R). RESULTS: Out of 65 patients, 58 demonstrated signs of spasticity (89%; MAS≥1), including 40 who showed severe spasticity (61.5%; MAS≥3). Patients with spasticity receiving anti-spastic medication were more spastic than unmedicated patients. A negative correlation was observed between the severity of spasticity and the frequency of physical therapy. MAS scores correlated positively with time since injury and NCS-R scores. We did not observe a difference of spasticity between the diagnoses. CONCLUSION: A large proportion of patients with disorders of consciousness develop severe spasticity, possibly affecting their functional recovery and their quality of life. The observed correlation between degrees of spasticity and pain scores highlights the importance of pain management in these patients with altered states of consciousness. Finally, the relationship between spasticity and treatment (i.e., pharmacological and physical therapy) should be further investigated in order to improve clinical care. CLINICAL REHABILITATION IMPACT: Managing spasticity at first signs could improve rehabilitation of patients with disorders of consciousness and maximize their chances of recovery. In addition, decreasing this trouble could allow a better quality of life for these non-communicative patients.


Subject(s)
Cognitive Behavioral Therapy/methods , Consciousness/physiology , Exercise Therapy/methods , Motor Activity/physiology , Muscle Spasticity/rehabilitation , Persistent Vegetative State/rehabilitation , Adult , Brain Injuries/complications , Brain Injuries/rehabilitation , Cross-Sectional Studies , Female , Humans , Male , Muscle Spasticity/etiology , Muscle Spasticity/physiopathology , Persistent Vegetative State/etiology , Persistent Vegetative State/physiopathology , Prognosis , Recovery of Function
12.
Encephale ; 38(2): 133-40, 2012 Apr.
Article in French | MEDLINE | ID: mdl-22516271

ABSTRACT

OBJECTIVES: Most people recognize that incarceration alone will not solve sexual violence. Treating the offenders is critical in an approach to preventing sexual violence and reducing victimization. The Law of June 17, 1998, on the prevention and repression of sexual offences, as well as the protection of minors, makes a provision for the possibility of medical and psychological monitoring adapted to these particular individuals. Sex offenders may well be constrained, after their incarceration, to social and judicial follow-up, which may include coerced treatment in order to reduce the risk of recidivism. In order to control this follow-up, the legislature has created the position of medical coordinator, who acts as an interface between justice and care in conjunction with the treating physician. This study is the first attempt to evaluate the activity of physician coordinators conducted in France since the implementation in 2004 of the 1998 law on monitoring sex offenders. METHODS: An interview of all the physician coordinators in Upper Normandy was conducted. The files of all sex offenders subjected to coerced treatment were studied. RESULTS: In our sample of 100 sex offenders who were subjected to coerced treatment (any kind of treatment) (99% men, 60% of sexual assaults on minors, 14% of cases of indecent exposure), minor victims of sexual assault were: 78% females; in 90% of cases the victim was aged under 14 years (under 10 in 52% of cases), 60% of cases were intrafamilial incest; the victim was an unknown aggressor in only one case out of 60. The constraint follow-up contributed to reducing the risk of recidivism (three cases of recidivism in 100 individuals over an average duration of follow-up of five years), although it remains difficult to assess the recidivism over a duration of time as short as five years. A diagnosis of paraphilia was only applied in 19% of cases (in 10 cases pedophilia, exhibitionism in nine cases). Only six subjects were receiving antiandrogen treatment. A diagnosis based on Axis I DSM was established in 57% of cases. Personality disorders were mentioned in the medical records in 65% of cases. An antisocial personality disorder was not prominent (20%). In 56 cases, the individuals had been victims of physical, psychological or sexual abuse. Nearly half of the individuals had a past history of sexual or non sexual offences, among those, 16 subjects had previously been convicted at least three times. The seniority of the prior conviction was more than 10 years in 43% of cases. Physician coordinators interviewed were satisfied with their work and felt they had contributed to improving the care of patients who had committed sexual offences. CONCLUSION: However, this study shows the need to create a national reference centre, which could enable a multidisciplinary evaluation of difficult cases and could also boost the development of research in this area where many questions remain unanswered, particularly regarding the determinants of deviant sexual behaviour and risk factors for recidivism.


Subject(s)
Sex Offenses/legislation & jurisprudence , Violence/legislation & jurisprudence , Adolescent , Adult , Androgen Antagonists/therapeutic use , Child , Coercion , Comorbidity , Cooperative Behavior , Crime Victims/legislation & jurisprudence , Crime Victims/psychology , Female , Follow-Up Studies , France , Humans , Incest/legislation & jurisprudence , Incest/prevention & control , Incest/psychology , Interdisciplinary Communication , Male , Mental Disorders/diagnosis , Mental Disorders/psychology , Mental Disorders/therapy , Middle Aged , Paraphilic Disorders/diagnosis , Paraphilic Disorders/psychology , Paraphilic Disorders/therapy , Patient Care Team/legislation & jurisprudence , Pedophilia/diagnosis , Pedophilia/psychology , Pedophilia/therapy , Prisoners/legislation & jurisprudence , Prisoners/psychology , Secondary Prevention , Sex Offenses/prevention & control , Sex Offenses/psychology , Socialization , Violence/prevention & control , Violence/psychology , Young Adult
13.
Transplant Proc ; 43(9): 3396-7, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22099805

ABSTRACT

Organ donation after cardiac death has been used for kidney and liver procurement in France since 2006. Until recently, most teams relied on in situ cold perfusion to prepare the donor before organ retrieval. Our team has used since 2007 normothermic abdominal recirculation. While this technique is presumed to be more difficult to implement, it also ensures a lower rate of primary nonfunction when compared to in situ cold perfusion. We present the efficiency results of our organ donation after cardiac death program. After 3 years, we have been able to establish a program in which we use normothermic abdominal recirculation in 97% of donors after cardiac death. The yearly efficiency of this program is comparable to the national efficiency of organ procurement from conventional deceased donors in France.


Subject(s)
Death , Tissue Donors , Tissue and Organ Procurement/methods , Efficiency , France , Graft Survival , Humans , Kidney Transplantation/methods , Liver Transplantation/methods , Perfusion , Prospective Studies , Tissue and Organ Harvesting , Tissue and Organ Procurement/organization & administration , Transplantation/methods
16.
Eur Neuropsychopharmacol ; 20(12): 829-38, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20926264

ABSTRACT

The incidence of suicide attempts (fatal and non-fatal) was analysed in a prospective cohort of patients with schizophrenia randomly assigned to sertindole (4905 patients) or risperidone (4904 patients) in a parallel-group open-label study with blinded classification of outcomes (the sertindole cohort prospective study--SCoP). The total exposure was 6978 and 7975 patient-years in the sertindole and risperidone groups, respectively. Suicide mortality in the study was low (0.21 and 0.28 per 100 patients per year with sertindole and risperidone, respectively). The majority (84%) of suicide attempts occurred within the first year of treatment. Cox's proportional hazards model analysis of the time to the first suicide attempt, reported by treating psychiatrists and blindly reviewed by an independent expert group according to the Columbia Classification Algorithm of Suicide Assessment (both defining suicide attempts by association of suicidal act and intent to die), showed a lower risk of suicide attempt for sertindole-treated patients than for risperidone-treated patients. The effect was statistically significant with both evaluation methods during the first year of randomized treatment (hazard ratios [95% CI]: 0.5 [0.31-0.82], p=0.006; and 0.57 [0.35-0.92], p=0.02, respectively). With classification by an independent safety committee using a broader definition including all incidences of intentional self-harm, also those without clear suicidal intent, the results were not significant. A history of previous suicide attempts was significantly associated with attempted suicides in both treatment groups.


Subject(s)
Imidazoles/therapeutic use , Indoles/therapeutic use , Risperidone/therapeutic use , Schizophrenia/drug therapy , Suicide Prevention , Suicide, Attempted/prevention & control , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Middle Aged , Prospective Studies , Risk Factors , Schizophrenia/complications , Single-Blind Method , Suicide/psychology , Suicide, Attempted/psychology , Treatment Outcome , Young Adult
17.
Acta Psychiatr Scand ; 122(5): 345-55, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20384598

ABSTRACT

OBJECTIVE: To explore whether sertindole increases all-cause mortality or cardiac events requiring hospitalization, compared with risperidone. METHOD: Multinational randomized, open-label, parallel-group study, with blinded classification of outcomes, in 9858 patients with schizophrenia. RESULTS: After 14147 person-years, there was no effect of treatment on overall mortality (sertindole 64, risperidone 61 deaths, Hazard Ratio (HR) = 1.12 (90% CI: 0.83, 1.50)) or cardiac events requiring hospitalization [sertindole 10, risperidone 6, HR = 1.73 (95% CI: 0.63, 4.78)]: Of these, four were considered arrhythmia-related (three sertindole, one risperidone). Cardiac mortality was higher with sertindole (Independent Safety Committee (ISC): 31 vs. 12, HR=2.84 (95% CI: 1.45, 5.55), P = 0.0022; Investigators 17 vs. 8, HR=2.13 (95% CI: 0.91, 4.98), P = 0.081). There was no significant difference in completed suicide, but fewer sertindole recipients attempted suicide (ISC: 68 vs. 78, HR=0.93 (95% CI: 0.66, 1.29), P = 0.65; Investigators: 43 vs. 65, HR=0.67 (95% CI: 0.45, 0.99), P = 0.044). CONCLUSION: Sertindole did not increase all-cause mortality, but cardiac mortality was higher and suicide attempts may be lower with sertindole.


Subject(s)
Antipsychotic Agents/adverse effects , Imidazoles/adverse effects , Indoles/adverse effects , Risperidone/adverse effects , Schizophrenia/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Antipsychotic Agents/therapeutic use , Arrhythmias, Cardiac/chemically induced , Female , Heart Diseases/chemically induced , Heart Diseases/mortality , Hospitalization/statistics & numerical data , Humans , Imidazoles/therapeutic use , Indoles/therapeutic use , Male , Middle Aged , Proportional Hazards Models , Prospective Studies , Risperidone/therapeutic use , Schizophrenia/mortality , Suicide, Attempted/statistics & numerical data , Young Adult
18.
Encephale ; 36(1): 33-8, 2010 Feb.
Article in French | MEDLINE | ID: mdl-20159194

ABSTRACT

All around the world, the potential consequences of the increasing use of psychoactive substances during pregnancy are a major public health concern. It is estimated that 20 to 30% of pregnant women use tobacco, 15% use alcohol, 3 to 10% use cannabis and 0.5 to 3% use cocaine. The estimation of tobacco consumption during pregnancy is better known as compared with alcohol and substance use prevalence during pregnancy, which remains under estimated or unknown. For example, in France, the prevalence of cannabis and cocaine use during pregnancy is unknown. In general, the prevalence of drug or alcohol use during pregnancy is estimated by extrapolating data from epidemiological studies conducted in the general population (in France or in other countries). However, drug or alcohol use in the general population may dramatically vary from one country to another. Even if some studies have reported the prevalence of alcohol or substance use in different countries around the world, most of them were based on the mother's interview. In most cases, the mother did not report exactly the amount of drugs or alcohol used. Further studies measuring alcohol or substance use in the mother's blood, hair or in the newborn's meconium are needed. In addition, different methodologies have been used in the literature (different types of interview, with or without biological measurements; different subjects included (in- or out-pregnant women, psychiatric comorbidities or not, different economic status, etc). Despite these methodological biases, the prevalence of drug or alcohol use increases in pregnant women, and in most cases, several drugs are associated. Most of the studies have used structured or semi-structured interviews such as the addiction severity index (ASI) or the alcohol use disorders identification test (AUDIT) to assess alcohol or drug consumption. In addition, the identification of risk factors for substance or alcohol use during pregnancy would allow the early detection of these high-risk pregnancies. Environmental factors such as low economic status or marital status may play an important role. Personality disorders may also contribute to substance or alcohol use during pregnancy. In fact, in most studies the quality of the obstetrical survey is lower in pregnant women using drugs or alcohol but it remains difficult to describe a specific at-risk profile in these pregnant women. Consumption of alcohol or of one or more psychoactive substances during pregnancy may have serious consequences on the pregnancy and on the child's development. Fetal alcoholism syndrome is the main etiology of mental retardation in France. We need to improve our knowledge of alcohol and substance use during pregnancy in order to target information for prevention campaigns and to implement specific mother and child medical care in high-risk populations.


Subject(s)
Pregnancy Complications/epidemiology , Psychotropic Drugs , Substance-Related Disorders/epidemiology , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Cocaine/adverse effects , Cross-Cultural Comparison , Cross-Sectional Studies , Female , France , Health Education , Humans , Infant, Newborn , Marijuana Abuse/epidemiology , Pregnancy , Psychotropic Drugs/adverse effects , Risk Factors , Smoking/adverse effects , Smoking/epidemiology
19.
Eur Psychiatry ; 25(2): 75-9, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19541456

ABSTRACT

The colour-word Emotional Stroop task (ES task) has been proposed to assess the interferences between emotion and attention. Using this task, first, we examined how attention (using reaction times) can be modified by emotionally relevant words in schizophrenics as compared with controls as a function of the emotional significance of the word; second, we tested the assumption that schizophrenics with the most negative symptoms will show higher impairment in relationship to negative emotional words. In general, schizophrenics were slower to react. In both groups, mean reaction times were slower for emotional as compared with neutral words. No significant differences were observed between negative and positive words either in schizophrenics (n=21) or in controls (n=20). Even in the most negative schizophrenic patients, there were no differences between negative and positive words. There were no significant interactions between type of stimulus and any clinical variables (PANSS negative or non negative categorization, etc.). Also, there were no statistically significant correlations between reaction times and neuroleptic dosage or anhedonia scores. In conclusion, schizophrenia patients showed the same degree of interference from emotional words as compared with controls. Moreover, patients with a higher level of negative symptoms did not differently experience positive and negative words.


Subject(s)
Attention , Emotions , Mental Recall , Neuropsychological Tests , Recognition, Psychology , Schizophrenia/diagnosis , Schizophrenic Psychology , Verbal Behavior , Adult , Case-Control Studies , Color Perception , Humans , Middle Aged , Pattern Recognition, Visual , Psychiatric Status Rating Scales , Reaction Time , Vocabulary
20.
Encephale ; 35(6): 538-43, 2009 Dec.
Article in French | MEDLINE | ID: mdl-20004284

ABSTRACT

INTRODUCTION: Deliberate self-injury is defined as the intentional, direct injuring of body tissue without suicidal intent. There are different types of deliberate self-mutilating behaviour: self cutting, phlebotomy, bites, burns, or ulcerations. Sometimes, especially among psychotic inpatients, eye, tongue, ear or genital self-mutilations have been reported. In fact, self-mutilation behaviour raises nosological and psychopathological questions. A consensus on a precise definition is still pending. Many authors consider self-mutilating behaviour as a distinct clinical syndrome, whereas others hold it to be a specific symptom of borderline personality disorder. Self-mutilating behaviour has been observed in 10 to 15% of healthy children, especially between the age of 9 and 18 months. These self mutilations are considered as pathological after the age of 3. Such behaviour is common among adolescents, with a higher proportion of females, and among psychiatric inpatients. Patients use different locations and methods for self-mutilation. Deliberate self harm syndrome is often associated with addictive behaviour, suicide attempt, and personality disorder. CLINICAL MATERIAL: We report on an observational study including 30 inpatients and we compared the data with the existing literature. As a matter of fact, until now, most of the papers deal with case reports or with very specific patterns of self-mutilation (eye, tongue or genital self-mutilations). Otherwise, papers report the relationships between self-mutilation and somatic or personality disorders (Lesh Nyhan syndrome, borderline personality disorder, dermatitis artefacta, self-mutilation in children following brachial plexus related to birth injury, mental retardation...). Our study included all self harmed patients who had been admitted to our psychiatric hospital (whatever the location and type of self-mutilation). Patients suffering from brain injury or mental retardation were excluded. RESULTS: In our sample, there was a higher percentage of women (29 women and 1 man) and the mean age was 18 (12 to 37). More than half of the patients were aged under 18. Single parent families were reported in 30% of cases. Thirty percent of patients had been physically or sexually abused during childhood. Sixty percent had a comorbid psychiatric disorder, 63% had been hospitalised previously (half of them twice or more). Seventy-three percent of patients had previously attempted suicide (notably deliberate self-poisoning and cutting) that was not considered as self-mutilating behaviour by the patients themselves. Each patient had self harmed themselves at least twice and most often different methods and locations were used (deliberate self harm of forearms 90%, thighs 26.7%, legs 16.7%, chest 10%, belly 10%, hands 6.9%, face 6.9%, arms 6.7%, and feet 3.3%). Addictive disorders, such as substance abuse (tobacco 46.7%; alcohol 23.3%; illicit drugs 16.7% mostly cannabis or cocaine) and eating disorders (33.3% and among them 50% of cases were restrictive anorexia nervosa) were often associated with a deliberate self harm syndrome. Three psychiatric diagnoses were often observed in our cohort: depressive disorder 36.7%; personality disorder 20%; psychosis 10% and depressive disorder associated with personality disorder 33.3%. In our sample, psychotic patients differed on several clinical aspects: the atypical location (abdomen, nails) and method (needles) of self-mutilating behaviour. None of them had been abused during childhood and none was suffering from addictive disorders.


Subject(s)
Mental Disorders/epidemiology , Self Mutilation/epidemiology , Self-Injurious Behavior/epidemiology , Adolescent , Adult , Age Factors , Behavior, Addictive/diagnosis , Behavior, Addictive/epidemiology , Behavior, Addictive/psychology , Child , Child Abuse/diagnosis , Child Abuse/psychology , Child Abuse/statistics & numerical data , Child Abuse, Sexual/diagnosis , Child Abuse, Sexual/psychology , Child Abuse, Sexual/statistics & numerical data , Comorbidity , Cross-Sectional Studies , Female , France , Health Surveys , Humans , Male , Mental Disorders/diagnosis , Mental Disorders/psychology , Patient Admission , Self Mutilation/diagnosis , Self Mutilation/psychology , Self-Injurious Behavior/diagnosis , Self-Injurious Behavior/psychology , Sex Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...